Ledger.Open graph →
SEC Form D · filed May 13, 2020

Lexaria Bioscience Corp

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Other
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Christopher Bunka · Vancouver, British Columbia, CanadaExec · DirectorAnthony Nanula · Clarence, NYExecAllan Spissinger · KELOWNA, British Columbia, CanadaExecChristopher Bunka · Vancouver, British Columbia, CanadaExec · DirectorJohn Docherty · KELOWNA, British Columbia, CanadaExec · DirectorNanco Associates Associates LLC · Clarence, NYDirectorAndrew Salter · San Marino, CAExec · DirectorAngel Vazquez · Miguel Hidalgo, CDMX, O5Exec · DirectorBrian Laibow · Los Angeles, CADirectorJordan Mikes · Los Angeles, CADirectorRobert Kennedy · Westport, CTExecPaul S. Nanula · Clarence, NYDirectorTed Mckechnie · KELOWNA, British Columbia, CanadaDirectorDavid Hansel · Red Bank, NJDirectorBrian Quigley · KELOWNA, British Columbia, CanadaDirectorNicholas Baxter · KELOWNA, British Columbia, CanadaDirectorJohn Thomas · San Marino, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗